Filing Details
- Accession Number:
- 0001127602-16-046112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-11 16:52:55
- Reporting Period:
- 2016-03-09
- Filing Date:
- 2016-03-11
- Accepted Time:
- 2016-03-11 16:52:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187406 | J Daniel Levangie | C/O Insulet Corporation 600 Technology Park Drive, Suite 200 Billerica MA 01821 | President, Drug Delivery | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-09 | 15,545 | $15.14 | 25,358 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-09 | 7,600 | $31.04 | 17,758 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-03-10 | 9,455 | $15.14 | 27,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-10 | 4,699 | $30.65 | 22,514 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-03-09 | 15,545 | $0.00 | 15,545 | $15.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-03-10 | 9,455 | $0.00 | 9,455 | $15.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,455 | 2021-11-01 | No | 4 | M | Direct | |
| 0 | 2021-11-01 | No | 4 | M | Direct |
Footnotes
- Includes 1,000 restricted stock units granted on June 3, 2013, which vest on April 30, 2016; 2,000 restricted stock units granted on June 2, 2014, which vest one-half of the total units on April 30, 2016 and one-half of the total units on April 30, 2017; and 6,813 performance share units granted on April 1, 2015, which vest one-third of the total performance share units on April 1, 2016, one-third of the total performance share units on April 1, 2017 and one-third of the performance share units on April 1, 2018, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $31.00 to $31.46. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $30.12 to $31.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.
Billionaire Hedge Funds
